Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
暂无分享,去创建一个
Spiros C. Denaxas | A. Banerjee | H. Hemingway | K. Khunti | D. Pillay | T. McDonagh | M. Noursadeghi | A. Rubboli | L. Pasea | H. Hemingway | G. Lip | M. Katsoulis | Honghan Wu | N. Pareek | K. Khunti | J. Byrne | Yu Hu | W. K. Wong | B. Williams | J. Teo | A. Bakhai | Yutao Guo | S. Chen | L. Pasea | A. Lai | M. Katsoulis | S. Denaxas | V. Nafilyan | B. Williams | A. Bakhai | D. Pillay | M. Noursadeghi | H. Wu | N. Pareek | D. Bromage | T. Mcdonagh | J. Byrne | J. T. Teo | A. Shah | B. Humberstone | L. V. Tang | A. S. Shah | A. Rubboli | Y. Guo | Y. Hu | C. L. Sudlow | G. Y. Lip | D. Bromage | A. Lai | Suliang Chen | Liang V. Tang | V. Nafilyan | C. Sudlow | A. Shah | B. Humberstone | A. Banerjee | Ben Humberstone
[1] Haniye Sadat Sajadi,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.
[2] Arturo Gonzalez-Izquierdo,et al. UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER , 2019, J. Am. Medical Informatics Assoc..
[3] I. J. Douglas,et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. , 2020, medRxiv.
[4] L. Smeeth,et al. Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients , 2017, PloS one.
[5] Scott D. Solomon,et al. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.
[6] P. Maulik,et al. Global Alliance for Chronic Disease researchers' statement on multimorbidity. , 2018, The Lancet. Global health.
[7] Jennifer Jamieson,et al. Non-Communicable Diseases in Emergencies: A Call to Action , 2013, PLoS currents.
[8] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[9] Yaolong Chen,et al. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines , 2020, Thrombosis and Haemostasis.
[10] Spiros Denaxas,et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people , 2015, The Lancet.
[11] W. Liang,et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China , 2020, Chest.
[12] Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19 , 2020, European journal of preventive cardiology.
[13] P. Home. Cardiovascular outcome trials of glucose-lowering medications: an update , 2019, Diabetologia.
[14] Spiros Denaxas,et al. Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults , 2020, medRxiv.
[15] Lynnette Brammer,et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[16] Amitava Banerjee,et al. Can the NHS be a learning healthcare system in the age of digital technology? , 2018, BMJ Evidence-Based Medicine.
[17] S. Bosari,et al. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak , 2020, medRxiv.
[18] F. Fedele,et al. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy , 2020, The New England journal of medicine.
[19] Zhaofeng Chen,et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[20] Rui Ji,et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[21] Scott D. Solomon,et al. Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.
[22] C. Sudlow,et al. Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December – 20 April suggest underestimation of COVID-19 related deaths , 2020 .
[23] R. de Caterina,et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era , 2020, European heart journal.
[24] A. Banerjee,et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency , 2020, medRxiv.
[25] S. Hagard. England , 1995, The Knight and the Blast Furnace.